Skip to main content
Book Chapter

Management of Hematologic Disease in Mastocytosis

  • Yun H
  • Ustun C
Springer International Publishing, (2020), 231-255
DOI: 10.1007/978-3-030-27820-5_14
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Systemic mastocytosis (SM) with an associated hematologic neoplasm (SM-AHN) has generally poor prognosis and therefore considered a subtype of advanced SM (advSM). Other subtypes of advSM are aggressive SM and mast cell leukemia. Myeloid neoplasms such as chronic...

Cite

CITATION STYLE

APA

Yun, H. D., & Ustun, C. (2020). Management of Hematologic Disease in Mastocytosis. In Mastocytosis (pp. 231–255). Springer International Publishing. https://doi.org/10.1007/978-3-030-27820-5_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free